PATASHNIK, SHULAMI,LICHT, DANIELLA,GILBERT, ADRIAN
申请号：
CA2899472
公开号：
CA2899472C
申请日:
2007.06.12
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
The invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable salt of N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3- carboxamide, N-methylglucamine, and a pharmaceutically acceptable carrier.
